Apatinib as targeted therapy for sarcoma

Por Li, Feng, Liao, Zhichao, Zhang, Chao, Zhao, Jun, Xing, Ruwei, Teng, Sheng, Zhang, Jin, Yang, Yun, Yang, Jilong
Publicado no Oncotarget (2018)

Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China

Por Liao, Zhichao, Qiu, Minghan, Yang, Jilong, Yang, Yun, Zhu, Lei, Yang, Bo, Bai, Xu, Xing, Peipei, Zhang, Jin, Xing, Ruwei, Teng, Sheng, Zhao, Jun
Publicado no Sci Rep (2019)

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety

Por Liao, Zhichao, Li, Feng, Zhang, Chao, Zhu, Lei, Shi, Yehui, Zhao, Gang, Bai, Xu, Hassan, Shafat, Liu, Xinyue, Li, Ting, Xing, Peipei, Zhao, Jun, Zhang, Jin, Xing, Ruwei, Teng, Sheng, Yang, Yun, Chen, Kexin, Yang, Jilong
Publicado no Exp Mol Med (2019)

Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV

Por Xing, Peipei, Zhang, Jin, Yan, Zhao, Zhao, Gang, Li, Xubin, Wang, Guowen, Yang, Yun, Zhao, Jun, Xing, Ruwei, Teng, Sheng, Ma, Yulin, Liao, Zhichao, Ren, Zhiwu, Zhang, Chao, Han, Xiuxin, Zhang, Wei, Chen, Kexin, Wang, Ping, Yang, Jilong
Publicado no Oncotarget (2016)